In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • October 2, 2017
    Seeking Alpha

    ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price.

  • September 14, 2017
    San Diego Business Journal

    San Diego-based companies like ResMed and NuVasive Inc. argue the tax stifles research and development, job creation and innovation.

  • September 12, 2017
    HME News

    The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in patients with obstructive sleep apnea, according to a ResMed-supported study published in American Journal of Respiratory and Clinical Care Medicine.

  • September 5, 2017
    Parks Associates

    Kari Hall, VP, Global Software Services at ResMed, recently spoke with Parks Associates about the future of healthcare. Kari was also a speaker at Parks Associates’ annual Connected Health Summit in San Diego, where she and speakers from 2bPrecise, Kaiser, Qualcomm, and UPMC Insurance Services spoke about the business opportunities available through precision medicine.

  • August 27, 2017
    RT Magazine

    “Because ALS is a progressive disease, many patients receive NIV via a life support device, like ResMed’s Astral ventilator, which can be utilized throughout the course of the disease," said Denise Hartsell, RRT, RPSGT, Senior Product Manager, Ventilation at ResMed.

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages